‘Vaccine tailor-made” for cancer seems to be successful
A trial where the oncologists groups of cancer patients treated with a so-called personalized vaccine seems to be successful.
That writes the Volkskrant on the basis of German and American research that was published in Nature.
This new way of treat with vaccines, which molecule for molecule are composed, can still not be widely applied. “The costs are still enormous, but can the next few years are drastically reduced as the process is automated,” says research leader Ugur Sahin against the Volkskrant.
The research took nineteen patients with advanced melanoma, a form of skin cancer. They were first operated and then treated with a molecuulcocktail, which was composed after the study of the molecular characteristics of the tumors.
In Germany remained the cancer is gone at eight of the thirteen patients. Two died and another was the disease still road. In the United States continued to be the disease a few years away with four of the six patients. In the other two disappeared metastases after the immune system extra was performed.
Hope In the future the researchers also development of vaccines for other types of cancer.